Thursday, 15 October 2026European Markets

SAMSE And GENERAL ELECTRIC Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - samse (sams.pa) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
samse (sams.pa) €184.50 5.49% 12.56%
general electric (gne.pa) €161.00 0.69% 13.64%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. samse (sams.pa)

5.49% forward dividend yield and 12.56% return on equity

samse sa distributes building materials and tools in france. the company offers public works, roads, and sanitation products; construction materials and structural works; plaster, ceiling, and insulation; frame and roof; wood and panels; doors, windows, and joinery; floor and wall coverings; electricity, plumbing, sanitary, and heating; terrace and garden products, as well as tools, materials, hardware, and security. it serves customers through points of sales in auvergne-rhône-alpes, paca, and gard. the company was founded in 1920 and is headquartered in grenoble, france. samse sa is a subsidiary of dumont investissement.

earnings per share

as for profitability, samse has a trailing twelve months eps of €24.07.

pe ratio

samse has a trailing twelve months price to earnings ratio of 7.67. meaning, the purchaser of the share is investing €7.67 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.56%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on jun 20, 2024, the estimated forward annual dividend rate is 10 and the estimated forward annual dividend yield is 5.49%.

more news about samse.

2. general electric (gne.pa)

0.69% forward dividend yield and 13.64% return on equity

general electric company, doing business as ge aerospace, designs and produces commercial and defense aircraft engines, integrated engine components, electric power, and mechanical aircraft systems. it also offers aftermarket services to support its products. the company operates in the united states, europe, china, asia, the americas, the middle east, and africa. general electric company was incorporated in 1892 and is based in evendale, ohio.

earnings per share

as for profitability, general electric has a trailing twelve months eps of €7.37.

pe ratio

general electric has a trailing twelve months price to earnings ratio of 21.85. meaning, the purchaser of the share is investing €21.85 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.64%.

more news about general electric.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com